Multiple Sclerosis Market To Reach USD 39.9 Billion By 2032, Report By DataHorizzon Research

Advertisement

The multiple sclerosis market size was valued at USD 25.8 Billion in 2022 and is expected to reach a market size of USD 39.9 Billion by 2032 at a CAGR of 4.6%.

Fort Collins, Colorado, April 25, 2024 (GLOBE NEWSWIRE) —

Rise in cases of multiple sclerosis to trigger the need for vaccines and diagnosis.

Advertisement

Multiple sclerosis (MS) is a condition characterized by the immune system’s assault on the brain and spinal cord. Symptoms vary widely among individuals and hinge on the extent and location of nerve fiber damage. Common signs include vision disturbances, fatigue, difficulties with mobility and balance, and limb weakness or swelling. These symptoms may fluctuate in intensity and duration, with some persisting over extended periods.

The impact of multiple sclerosis extends across motor, sensory, cognitive, and emotional functions, stemming from the immune system’s attack on the central nervous system. The World Health Organization (WHO) estimates that over 1.8 million individuals grapple with multiple sclerosis globally. Treatment strategies vary depending on the severity of the disease and the specific symptoms exhibited. However, early intervention with medications can significantly improve outcomes.

MS is typified by inflammatory demyelination, activated by an autoimmune onslaught on myelin—the protective sheath encasing nerves in the brain and spinal cord. This autoimmune attack disrupts the transmission of electrical impulses along nerves, leading to the formation of scar tissue (known as plaque or sclerosis) and further exacerbating neurological dysfunction. 

Request Sample Report:

https://bit.ly/49NRZVH

Segmentation Overview:

The multiple sclerosis market has been segmented into drug class, route of administration, distribution channel, and region.

Injection is the leading segment for the route of administration and is projected to remain dominant in the coming years.

  • Based on the route of administration, the market is further categorized into oral and injection. The injection segment holds a prominent share in the multiple sclerosis market. Self-injectable medications make up the largest category of DMTs (Disease-modifying therapies). They are used for the long-term treatment of relapsing-remitting MS (RRMS). Another type of injectable option for treating MS is intravenous infusion. Infusions go directly into a vein instead of entering the system intramuscularly or subcutaneously. 

Immunosuppressants accounted for a significant market share in 2023.

  • The drug class segment comprises immunomodulators, immunosuppressants, and interferons. The immunosuppressants segment led the market growth with most of the share in 2023. Immunosuppressive therapy has been used to treat multiple sclerosis (MS) for over 30 years based on the hypothesis that MS is a T-cell-mediated autoimmune disease. 

Ask For Discount 

https://bit.ly/3QgZJc1

Multiple Sclerosis Market Report Highlights:

  • The multiple sclerosis market growth is anticipated at a CAGR of 4.6% by 2032.
  • The introduction of disease-modifying drugs fosters market growth. 
  • North America leads the multiple sclerosis market growth with most of the revenue share. MS is relatively common in the United States and Canada, with higher prevalence in northern latitudes. Genetic factors, along with potential environmental influences, contribute to the incidence.
  • Some prominent players in the multiple sclerosis market report include Biogen, Pfizer Inc., F. Hoffman-La Roche Ltd, Novartis AG, Merck & Co, Inc., Sanofi, Teva Pharmaceutical Industries Ltd., and Bristol-Myers Squibb Company among others.

Looking Exclusively For Region/Country Specific Report? 

https://bit.ly/3w4Bln7

About DataHorizzon Research:

DataHorizzon is a market research and advisory company that assists organizations across the globe in formulating growth strategies for changing business dynamics. Its offerings include consulting services across enterprises and business insights to make actionable decisions. DHR’s comprehensive research methodology for predicting long-term and sustainable trends in the market facilitates complex decisions for organizations.

Contact:

Mail: [email protected]

Ph: +1-970-672-0390

Website: https://datahorizzonresearch.com/

Follow Us: LinkedIn 

 

Recent Publications

Tissue Nanotransfection Market 2024 to 2032

Regulatory Affair Outsourcing Market 2024 to 2032

Pain Management Therapeutics Market 2024 to 2032

Life Science Tools And Reagents Market 2024 to 2032

Medical Billing Outsourcing Market 2024 to 2032

CONTACT: Mail: [email protected] Ph: +1-970-672-0390 Website: https://www.datahorizzonresearch.com 

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. AfternoonHeadlines.com takes no editorial responsibility for the same.